| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |